Literature DB >> 7434066

Renal agenesis after first trimester exposure to chlorambucil.

J F Steege, D S Caldwell.   

Abstract

One of a set of twins aborted at 20 weeks' gestation had unilateral renal agenesis after exposure to chlorambucil and prednisone since conception. There are no firm clinical data suggesting that second or third trimester exposure to any of the immunosuppressive drugs is toxic to the fetus, and no absolute cause-and-effect relationship is established in this case.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7434066     DOI: 10.1097/00007611-198010000-00040

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  7 in total

1.  Renal anomalies in family members of infants with bilateral renal agenesis/adysplasia.

Authors:  Andrew L Schwaderer; Carlton M Bates; Kirk M McHugh; Kim L McBride
Journal:  Pediatr Nephrol       Date:  2006-09-15       Impact factor: 3.714

2.  High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease.

Authors:  H H Tessler; T Jennings
Journal:  Br J Ophthalmol       Date:  1990-06       Impact factor: 4.638

Review 3.  Effects of maternally administered drugs on the fetal and neonatal kidney.

Authors:  Farid Boubred; Mariella Vendemmia; Patricia Garcia-Meric; Christophe Buffat; Veronique Millet; Umberto Simeoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 4.  Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?

Authors:  M Ostensen; R Ramsey-Goldman
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

5.  Twenty cases of sympathetic ophthalmia.

Authors:  T Jennings; H H Tessler
Journal:  Br J Ophthalmol       Date:  1989-02       Impact factor: 4.638

Review 6.  Optimisation of antirheumatic drug treatment in pregnancy.

Authors:  M Ostesen
Journal:  Clin Pharmacokinet       Date:  1994-12       Impact factor: 6.447

Review 7.  Human pregnancy safety for agents used to treat rheumatoid arthritis: adequacy of available information and strategies for developing post-marketing data.

Authors:  Christina D Chambers; Zuhre N Tutuncu; Diana Johnson; Kenneth L Jones
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.